METASTATIC COLORECTAL CANCER
Clinical trials for METASTATIC COLORECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to outsmart Drug-Resistant colorectal cancer
Disease control Not yet recruitingThis study tests whether drug combinations chosen based on each person's tumor characteristics can help control metastatic colorectal cancer. About 100 adults with a specific type of colorectal cancer will receive personalized treatments. The main goal is to check safety and side…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for Hard-to-Treat colorectal cancer: immunotherapy before surgery
Disease control Not yet recruitingThis study tests whether giving immunotherapy before surgery can help people with a certain type of colorectal cancer that has spread to the liver. The cancer is called microsatellite stable (MSS), which usually does not respond well to immunotherapy. About 24 adults will receive…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New combo shows promise in colorectal cancer battle
Disease control Not yet recruitingThis study compares two drug combinations for people with advanced colorectal cancer that has not spread to the liver. Participants will receive either ivonescimab plus chemotherapy or bevacizumab plus chemotherapy every two weeks. The goal is to see which combination better dela…
Matched conditions: METASTATIC COLORECTAL CANCER
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 04, 2026 16:29 UTC